Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS Louisiana Medical Policy Updates – September 2024
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
September 2024 BCBS Louisiana Medical Policy Updates:
- ADAMTS13, recombinant-krhn (Adzynma™)
- aducanumab-avwa (Aduhelm™)
- Advanced Therapies for Pharmacological Treatment of Pulmonary Hypertension
- Alpelisib (Vijoice®)
- amifampridine (Firdapse®‡, Ruzurgi™‡)
- Angiotensin II Receptor Blockers and Angiotensin II Receptor Blocker Combination Drugs
- brexanolone (Zulresso™)
- Calcitonin Gene-Related Peptide (CGRP) Antagonists
- Chimeric Antigen Receptor T-cell (CAR-T) Therapy
- Drug Testing in Pain Management and Substance Use Disorder Treatment
- edaravone (Radicava™)
- Elective Delivery of Pregnancy
- Endovascular Stent Grafts for Abdominal Aortic Aneurysms
- Experimental-Investigational Services
- fosdenopterin (Nulibry™)
- Fumaric Acids for the Treatment of Multiple Sclerosis
- GLP-1 Agonists for Diabetes
- Ingestible pH and Pressure Capsule
- Insulins (Non-Long Acting Products)
- Intradialytic Parenteral Nutrition
- Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
- Laser Treatment of Onychomycosis
- Lipid Apheresis
- Lovaza® (omega-3-acid ethyl esters capsules)
- Lymphedema Pumps
- Migraine Medications (Oral, Injectable, Transdermal, and Nasal)
- Navigated Transcranial Magnetic Stimulation
- Netarsudil Ophthalmic Products (Rhopressa®, Rocklatan®)
- Olipudase alfa-rpcp (Xenpozyme®)
- Oravig® (miconazole buccal tablets)
- Overactive Bladder Medications (Branded)
- Parathyroid Hormone (Natpara®)
- Parenteral Nutrition and Enteral Nutrition Therapy in the Home
- Percutaneous Intradiscal Electrothermal Annuloplasty, Radiofrequency Annuloplasty, Biacuplasty and Intraosseous Basivertebral Nerve Ablation
- Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
- Prograf® granules (tacrolimus)
- Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors [alirocumab (Praluent®), evolocumab (Repatha™)]
- Rayos® (prednisone delayed release tablets)
- Romosozumab-Aqqg (Evenity™)
- Ruxolitinib (Opzelura™)
- Sedative Hypnotics
- Select Drugs for Constipation
- Select Glipizide Products
- Sinus Ostial Dilatation with Balloon Catheter for Rhinosinusitis
- Solosec™ (secnidazole)
- Sunosi™ (solriamfetol)
- Surgical Deactivation of Headache Trigger Sites
- Temporomandibular Joint Dysfunction
- Therapeutic Radiopharmaceuticals in Oncology
- Topical Antipruritics
- Transcatheter Mitral Valve Repair
- Upadacitinib (Rinvoq™)
- Velmanase Alfa-tycv (Lamzede®)
- Vtama® (tapinarof)
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
